Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast CancerEleni Andreopoulou, Franco M. Muggia, Eugene S. Kim et al.|Clinical Breast Cancer|2007Cited by 31